Wellington Shields Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $18.3K | Sell |
233
-200
| -46% | -$16.1K | ﹤0.01% | 324 |
|
|
2026
Q1 | $37.5K | Sell |
433
-117
| -21% | -$11.2K | 0.01% | 301 |
|
|
2025
Q4 | $52.8K | Hold |
550
| – | – | 0.01% | 290 |
|
|
2025
Q3 | $52.4K | Hold |
550
| – | – | 0.01% | 306 |
|
|
2025
Q2 | $47.9K | Buy |
550
+200
| +57% | +$17K | 0.01% | 298 |
|
|
2025
Q1 | $31.5K | Hold |
350
| – | – | 0.01% | 296 |
|
|
2024
Q4 | $28K | Hold |
350
| – | – | ﹤0.01% | 295 |
|
|
2024
Q3 | $31.5K | Hold |
350
| – | – | 0.01% | 298 |
|
|
2024
Q2 | $27.5K | Sell |
350
-170
| -33% | -$13.9K | 0.01% | 293 |
|
|
2024
Q1 | $45.3K | Sell |
520
-650
| -56% | -$55.5K | 0.01% | 286 |
|
|
2023
Q4 | $96.4K | Hold |
1,170
| – | – | 0.01% | 260 |
|
|
2023
Q3 | $91.7K | Hold |
1,170
| – | – | 0.01% | 262 |
|
|
2023
Q2 | $103K | Hold |
1,170
| – | – | 0.01% | 257 |
|
|
2023
Q1 | $94.3K | Buy |
+1,170
| New | +$95.4K | 0.01% | 266 |
|
|
2022
Q2 | – | Sell |
-585
| Closed | -$65K | – | 312 |
|
|
2022
Q1 | $65K | Sell |
585
-7,827
| -93% | -$827K | 0.01% | 287 |
|
|
2021
Q4 | $870K | Buy |
8,412
+2,977
| +55% | +$345K | 0.11% | 159 |
|
|
2021
Q3 | $681K | Sell |
5,435
-2,977
| -35% | -$385K | 0.09% | 153 |
|
|
2021
Q2 | $1.04M | Hold |
8,412
| – | – | 0.13% | 137 |
|
|
2021
Q1 | $994K | Sell |
8,412
-15
| -0.2% | -$1.76K | 0.09% | 146 |
|
|
2020
Q4 | $987K | Sell |
8,427
-713
| -8% | -$78.5K | 0.13% | 127 |
|
|
2020
Q3 | $950K | Sell |
9,140
-16
| -0.2% | -$1.61K | 0.15% | 105 |
|
|
2020
Q2 | $840K | Buy |
9,156
+186
| +2% | +$17.8K | 0.13% | 118 |
|
|
2020
Q1 | $809K | Buy |
8,970
+3,610
| +67% | +$384K | 0.15% | 110 |
|
|
2019
Q4 | $608K | Hold |
5,360
| – | – | 0.09% | 162 |
|
|
2019
Q3 | $582K | Buy |
5,360
+1,350
| +34% | +$141K | 0.09% | 163 |
|
|
2019
Q2 | $391K | Hold |
4,010
| – | – | 0.06% | 205 |
|
|
2019
Q1 | $365K | Hold |
4,010
| – | – | 0.06% | 213 |
|
|
2018
Q4 | $365K | Buy |
4,010
+65
| +2% | +$6.07K | 0.07% | 202 |
|
|
2018
Q3 | $388K | Hold |
3,945
| – | – | 0.06% | 224 |
|
|
2018
Q2 | $338K | Hold |
3,945
| – | – | 0.06% | 231 |
|
|
2018
Q1 | $316K | Sell |
3,945
-4,211
| -52% | -$347K | 0.05% | 255 |
|
|
2017
Q4 | $659K | Buy |
8,156
+4,306
| +112% | +$345K | 0.1% | 188 |
|
|
2017
Q3 | $299K | Sell |
3,850
-300
| -7% | -$24.9K | 0.05% | 265 |
|
|
2017
Q2 | $368K | Hold |
4,150
| – | – | 0.06% | 243 |
|
|
2017
Q1 | $334K | Hold |
4,150
| – | – | 0.05% | 245 |
|
|
2016
Q4 | $296K | Sell |
4,150
-400
| -9% | -$31.4K | 0.05% | 256 |
|
|
2016
Q3 | $393K | Hold |
4,550
| – | – | 0.07% | 237 |
|
|
2016
Q2 | $395K | Hold |
4,550
| – | – | 0.07% | 232 |
|
|
2016
Q1 | $341K | Sell |
4,550
-3,000
| -40% | -$226K | 0.06% | 244 |
|
|
2015
Q4 | $581K | Buy |
7,550
+2,496
| +49% | +$188K | 0.1% | 175 |
|
|
2015
Q3 | $338K | Hold |
5,054
| – | – | 0.06% | 231 |
|
|
2015
Q2 | $375K | Sell |
5,054
-992
| -16% | -$75.8K | 0.06% | 254 |
|
|
2015
Q1 | $472K | Buy |
6,046
+996
| +20% | +$75.5K | 0.07% | 222 |
|
|
2014
Q4 | $365K | Buy |
+5,050
| New | +$351K | 0.06% | 250 |
|
Other funds holding MDT
Wellington Shields Capital Management's MDT Position: Q2 2026 in Review
Wellington Shields Capital Management reduced its Medtronic (MDT) stake by 46% in Q2 2026, selling an estimated $16.1K and leaving 233 shares worth $18.3K. The position accounts for ﹤0.01% of the portfolio, ranked #324.
Wellington Shields Capital Management first reported a position in MDT in Q4 2014 and has held it in 44 quarters since. The position peaked at $1.04M in Q2 2021. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Wellington Shields Capital Management held 233 shares of Medtronic worth $18.3K as of Q2 2026.
- Wellington Shields Capital Management sold 200 Medtronic shares in Q2 2026, an estimated $16.1K.
- Medtronic made up ﹤0.01% of Wellington Shields Capital Management's portfolio in Q2 2026, its #324 holding.
- Wellington Shields Capital Management first reported a position in Medtronic in Q4 2014 and has held it in 44 quarters since.
- Wellington Shields Capital Management's Medtronic position peaked at $1.04M in Q2 2021.
- 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Wellington Shields Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.